- Home
- IVAC vs VXRT Comparison
IVAC vs VXRT Comparison
Compare IVAC & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVAC
- VXRT
- Stock Information
- Founded
- IVAC 1990
- VXRT N/A
- Country
- IVAC United States
- VXRT United States
- Employees
- IVAC N/A
- VXRT N/A
- Industry
- IVAC Industrial Machinery/Components
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVAC Technology
- VXRT Health Care
- Exchange
- IVAC Nasdaq
- VXRT Nasdaq
- Market Cap
- IVAC 108.5M
- VXRT 119.0M
- IPO Year
- IVAC 1995
- VXRT N/A
- Fundamental
- Price
- IVAC N/A
- VXRT $0.35
- Analyst Decision
- IVAC Hold
- VXRT Strong Buy
- Analyst Count
- IVAC 1
- VXRT 2
- Target Price
- IVAC N/A
- VXRT $3.00
- AVG Volume (30 Days)
- IVAC 303.1K
- VXRT 1.8M
- Earning Date
- IVAC 04-24-2025
- VXRT 03-20-2025
- Dividend Yield
- IVAC 2.55%
- VXRT N/A
- EPS Growth
- IVAC N/A
- VXRT N/A
- EPS
- IVAC N/A
- VXRT N/A
- Revenue
- IVAC $63,978,000.00
- VXRT $28,700,000.00
- Revenue This Year
- IVAC N/A
- VXRT N/A
- Revenue Next Year
- IVAC N/A
- VXRT $48.02
- P/E Ratio
- IVAC N/A
- VXRT N/A
- Revenue Growth
- IVAC 21.48
- VXRT 288.94
- 52 Week Low
- IVAC $2.46
- VXRT $0.34
- 52 Week High
- IVAC $4.42
- VXRT $1.30
- Technical
- Relative Strength Index (RSI)
- IVAC 3.05
- VXRT 25.21
- Support Level
- IVAC $3.98
- VXRT $0.49
- Resistance Level
- IVAC $4.04
- VXRT $0.60
- Average True Range (ATR)
- IVAC 0.01
- VXRT 0.04
- MACD
- IVAC -0.28
- VXRT -0.01
- Stochastic Oscillator
- IVAC 0.00
- VXRT 4.69
About IVAC Intevac Inc.
Intevac Inc designs and develops high-productivity, thin-film processing systems. The company's production platforms are designed for high-volume manufacturing of substrates with precise thin-film properties, such as the hard disk drive, and display cover panel. The Thin Film Equipment segment also previously designed, developed, and marketed manufacturing equipment for the photovoltaic solar cell and semiconductor packaging industries. Geographically, the majority of its revenue is generated from Asia and the rest from the United States and Europe.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.